Fintel reports that on August 14, 2023, Barrington Research upgraded their outlook for Anika Therapeutics (NASDAQ:ANIK) from Market Perform to Outperform. As of August 2, 2023, the average one-year ...

We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now. In this article, we are going to take a look at where Anika Therapeutics, Inc. (NASDAQ:ANIK) stands against the other ...

Good evening, ladies and gentlemen, and welcome to Anika's First Quarter 2024 Earnings Conference Call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a ...

We recently compiled a list of the Top 10 Holdings of Caligan Partners. In this article, we are going to take a look at where Anika Therapeutics, Inc. (NASDAQ:ANIK) stands against Caligan Partners’ ...

Barrington analyst Michael Petusky maintained a Buy rating on Anika Therapeutics (ANIK – Research Report) today and set a price target of $24.00. The company’s shares opened today at $17.66. According ...

Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Anika Therapeutics develops and manufactures medical ...

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period. There have been no specific sales or earnings ...

Good evening, ladies and gentlemen, and welcome to Anika's Second Quarter 2022 Earnings Conference Call. [Operator Instructions] I will now turn the call over to Mark Namaroff, Vice President of ...

Anika Therapeutics (ANIK) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.25 per share a year ago. These ...